Insiders / Gibson Christopher / Activity
Activity — Gibson Christopher
27 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | Sell | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $178.8K | -40K -4.19% | 913,839 0.17% of shares | medium |
| Jan 5, 2026 | Sell | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $170.0K | -40K -4.11% | 933,839 0.17% of shares | medium |
| Feb 4, 2026 | Sell | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $164.8K | -40K -4.19% | 913,839 0.17% of shares | medium |
| Feb 19, 2026 | Sell | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $138.4K | -40K -4.23% | 906,556 0.17% of shares | medium |
| Mar 23, 2026 | Sell | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $130.0K | -40K -4.23% | 906,556 0.17% of shares | medium |
| Feb 17, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $95.2K | -27K -2.92% | 906,556 0.17% of shares | low |
| Feb 6, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $36.9K | -10K -1.10% | 933,821 0.17% of shares | low |
| Apr 8, 2026 | Grant | PACB Pacific Biosciences of California, Inc. Common Stock | $0 | +57K +106.60% | 111,386 0.04% of shares | low |
| Mar 23, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +40K +4.41% | 946,556 0.18% of shares | low |
| Mar 9, 2026 | Gift | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | -20K -2.16% | 906,556 0.17% of shares | low |
| Mar 9, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +20K +2.21% | 926,556 0.17% of shares | low |
| Feb 19, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +40K +4.41% | 946,556 0.18% of shares | low |
| Feb 6, 2026 | Grant | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +30K +3.32% | 944,185 0.18% of shares | low |
| Feb 4, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +40K +4.38% | 953,839 0.18% of shares | low |
| Jan 20, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +40K +4.38% | 953,839 0.18% of shares | low |
| Jan 5, 2026 | Gift | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | -20K -2.14% | 913,839 0.17% of shares | low |
| Jan 5, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +60K +6.57% | 973,839 0.18% of shares | low |
| Mar 3, 2026 | Grant | PACB Pacific Biosciences of California, Inc. Common Stock | $0 | +54K | 53,913 0.02% of shares | low |
| Jun 3, 2026 | Grant | PACB Pacific Biosciences of California, Inc. Stock Option (right to buy) | — | +74K | 74,497 0.02% of shares | low |
| Apr 8, 2026 | Grant | PACB Pacific Biosciences of California, Inc. Stock Option (right to buy) | — | +78K | 77,842 0.03% of shares | low |
| Mar 23, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -40K -0.88% | 4,483,334 0.84% of shares | low |
| Mar 9, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -20K -0.44% | 4,523,334 0.84% of shares | low |
| Feb 19, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -40K -0.87% | 4,543,334 0.85% of shares | low |
| Feb 4, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -40K -0.87% | 4,583,334 0.86% of shares | low |
| Jan 20, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -40K -0.86% | 4,623,334 0.86% of shares | low |
| Jan 5, 2026 | Other | RXRX Recursion Pharmaceuticals, Inc. Class B Common Stock | — | -60K -1.27% | 4,663,334 0.87% of shares | low |
| Mar 3, 2026 | Grant | PACB Pacific Biosciences of California, Inc. Stock Option (right to buy) | — | +73K | 73,087 0.02% of shares | low |